BPC-157 Clinical Trials: Registered Studies and Status
As of November 2, 2026, ClinicalTrials.gov lists 3 registered studies matching BPC-157 or its known aliases as an intervention.
Summary
- Registered studies
- 3
- Most advanced phase
- Phase 2
- Recruiting or not yet recruiting
- 2
- Most recent start
- 2027-01-01
- Most frequent lead sponsor
- Hudson Biotech (1)
- Most common status
- Not yet recruiting
Source: ClinicalTrials.gov, retrieved . Registry searches by name may miss studies that use other identifiers.
Registered studies
| NCT ID | Title | Phase | Status | Enrollment | Start | Lead sponsor |
|---|---|---|---|---|---|---|
| NCT07803250 | Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery | Phase 1 | Not yet recruiting | 30 | 2027-01-01 | University of Arkansas |
| NCT07437547 | BPC 157 for Acute Hamstring Muscle Strain Repair | Phase 2 | Recruiting | 120 | 2026-02-02 | Hudson Biotech |
| NCT02637284 | PCO-02 - Safety and Pharmacokinetics Trial | Phase 1 | Unknown | 42 | 2015-10 | PharmaCotherapia d.o.o. |
Method and limitations
- Data source: ClinicalTrials.gov API v2, intervention search.
- Query used:
"BPC-157" OR "Body Protection Compound-157" OR "PL 14736" OR "pentadecapeptide BPC 157" - Retrieved: November 2, 2026. Refreshed weekly; changes are reviewed before publication.
- Studies registered only under other names, sponsor codes, or in other registries may be missing.
- A match on name does not mean the study tested this peptide alone; some studies include it as a comparator or combination.
- Status values are reported by sponsors and may be out of date.